Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Comparison of three immunological tests for leprosy diagnosis and detection of subclinical infection.

Lobato J, Costa MP, Reis Ede M, Gonçalves MA, Spencer JS, Brennan PJ, Goulart LR, Goulart IM.

Lepr Rev. 2011 Dec;82(4):389-401.

PMID:
22439279
2.

Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region.

da Conceição Oliveira Coelho Fabri A, Carvalho AP, Araujo S, Goulart LR, de Mattos AM, Teixeira HC, Goulart IM, Duthie MS, Correa-Oliveira R, Lana FC.

BMC Infect Dis. 2015 May 30;15:218. doi: 10.1186/s12879-015-0962-4.

3.

Evaluation of a rapid serological test for leprosy classification using human serum albumin as the antigen carrier.

Moura RS, Penna GO, Fujiwara T, Pontes MA, Cruz R, Gonçalves Hde S, Penna ML, Cardoso LP, Stefani MM, Bührer-Sékula S.

J Immunol Methods. 2014 Oct;412:35-41. doi: 10.1016/j.jim.2014.06.014. Epub 2014 Jun 29.

PMID:
24983877
5.

Anti-PGL-I seroepidemiology in leprosy cases: household contacts and school children from a hyperendemic municipality of the Brazilian Amazon.

Barreto JG, Guimarães Lde S, Leão MR, Ferreira DV, Lima RA, Salgado CG.

Lepr Rev. 2011 Dec;82(4):358-70.

PMID:
22439276
6.

The result patterns of ML Flow and ELISA (PGL-I) serologic tests in leprosy-endemic and non-endemic areas.

Silva RC, Lyon S, Araos R, Lyon AC, Grossi MA, Lyon SH, Penido RA, Bührer-Sékula S, Antunes CM.

Rev Soc Bras Med Trop. 2008;41 Suppl 2:19-22.

7.

Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.

Desforges S, Bobin P, Brethes B, Huerre M, Moreau JP, Bach MA.

Int J Lepr Other Mycobact Dis. 1989 Dec;57(4):794-800.

PMID:
2681462
8.

Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.

Meeker HC, Schuller-Levis G, Fusco F, Giardina-Becket MA, Sersen E, Levis WR.

Int J Lepr Other Mycobact Dis. 1990 Sep;58(3):503-11.

PMID:
2205685
9.

Serological diagnosis of leprosy in patients in vietnam by enzyme-linked immunosorbent assay with Mycobacterium leprae-derived major membrane protein II.

Kai M, Nguyen Phuc NH, Hoang Thi TH, Nguyen AH, Fukutomi Y, Maeda Y, Miyamoto Y, Mukai T, Fujiwara T, Nguyen TT, Makino M.

Clin Vaccine Immunol. 2008 Dec;15(12):1755-9. doi: 10.1128/CVI.00148-08. Epub 2008 Oct 22.

10.

A study on performance of two serological assays for diagnosis of leprosy patients.

Parkash O, Chaturvedi V, Girdhar BK, Sengupta U.

Lepr Rev. 1995 Mar;66(1):26-30.

PMID:
7731338
11.

Correlation between ELISA and ML Flow assays applied to 60 Brazilian patients affected by leprosy.

Da Silva RC, Lyon S, Lyon AC, Grossi MA, Lyon SH, Bührer-Sékula S, Antunes CM.

Trans R Soc Trop Med Hyg. 2010 Aug;104(8):546-50. doi: 10.1016/j.trstmh.2010.05.001. Epub 2010 Jun 17.

PMID:
20621218
12.

Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients.

Parkash O, Kumar A, Nigam A, Franken KL, Ottenhoff TH.

Scand J Immunol. 2006 Oct;64(4):450-5.

13.

The ML flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients.

Bührer-Sékula S, Visschedijk J, Grossi MA, Dhakal KP, Namadi AU, Klatser PR, Oskam L.

Lepr Rev. 2007 Mar;78(1):70-9.

PMID:
17518099
14.

Comparison of two rapid tests for anti-phenolic glycolipid-I serology in Brazil and Nepal.

Stefani MM, Grassi AB, Sampaio LH, Sousa AL, Costa MB, Scheelbeek P, Neupane KD, Hagge DA, Macdonald M, Cho SN, Oskam L, Bührer-Sékula S.

Mem Inst Oswaldo Cruz. 2012 Dec;107 Suppl 1:124-31.

15.

Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy.

Menzel S, Harboe M, Bergsvik H, Brennan PJ.

Int J Lepr Other Mycobact Dis. 1987 Dec;55(4):617-25.

PMID:
3323365
16.

A study on the methods for early serological diagnosis of leprosy and their potential use.

Wu Q, Li X, Yin Y, Shu H, Wei W, Liu Q, Ye G.

Int J Lepr Other Mycobact Dis. 1999 Sep;67(3):302-5.

PMID:
10575411
17.

A study on a possibility of predicting early relapse in leprosy using a ND-O-BSA based ELISA.

Wu Q, Yin Y, Zhang L, Chen X, Yu Y, Li Z, Yu H, Lu C, Feng S, Li X, Huo W, Ye G.

Int J Lepr Other Mycobact Dis. 2002 Mar;70(1):1-8.

PMID:
12120035
18.

IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.

Ulrich M, Smith PG, Sampson C, Zuniga M, Centeno M, Garcia V, Manrique X, Salgado A, Convit J.

Int J Lepr Other Mycobact Dis. 1991 Sep;59(3):405-15.

PMID:
1890364
19.
20.

Active search for leprosy cases in Midwestern Brazil: a serological evaluation of asymptomatic household contacts before and after prophylaxis with bacillus Calmette-Guérin.

Limeira OM, Gomes CM, Morais OO, Cesetti MV, Alvarez RR.

Rev Inst Med Trop Sao Paulo. 2013;55(3). pii: S0036-46652013000300173. doi: 10.1590/S0036-46652013000300006.

Supplemental Content

Support Center